文献速递癫痫

老年癫痫或惊厥出院后门诊随访与30天再入院的相关性

Association of Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge in Medicare Beneficiaries Aged 65 and Older.
PubMed 文献 · Neurology · 2025-05-08

本研究基于2016-2019年Medicare索赔数据,纳入80,620例65岁以上因癫痫/惊厥住院的成人,回顾性分析出院后30天再入院率及门诊随访与再入院风险的关联。结果显示17.72%在30天内再入院,无随访者再入院率为22%,任何就诊者为6%;LASSO多变量模型中,早期初级保健随访(aOR 0.49)、早期神经科随访(aOR 0.39)、后期神经外科随访(aOR 0.42)、后期神经科随访(aOR 0.16)及后期初级保健随访(aOR 0.16)均与再入院 odds 降低相关。

要点

  • 65岁以上癫痫/惊厥住院患者30天再入院率为17.72%。
  • 无随访者再入院率22%,任何就诊者仅6%。
  • 早期初级保健或神经科随访与再入院 odds 降低相关。

核心结论

  • 老年癫痫或惊厥住院患者再入院率高,门诊随访与再入院 odds 降低相关。
  • 确保初级保健或神经科门诊随访可能是减少再入院的简易干预措施。

研究设计与样本

  • 回顾性队列研究,使用2016-2019年Medicare索赔数据,纳入80,620例65岁以上因癫痫/惊厥住院的成人。
  • 主要结局为30天内再入院,暴露为随访有无及随访提供者专科。
  • 随访期从入院前90天至出院后30天,采用LASSO方法筛选变量纳入最终模型。

主要发现

  • 80,620例中17.72%在30天内再入院。
  • 随访状态:20.6%仅看初级保健,2.5%仅神经科,0.3%仅神经外科,0.1%仅癫痫专科,5.4%有组合就诊。
  • 再入院率:无随访22% vs 任何就诊6%;仅初级保健8%,仅神经科5%,仅神经外科16%,仅癫痫专科1%,组合就诊2%。
  • LASSO多变量模型:早期(第1-15天)初级保健随访 aOR 0.49(95%CI 0.45-0.52,p<0.001);早期神经科随访 aOR 0.39(95%CI 0.33-0.46,p<0.001);后期(第16-30天)神经外科随访 aOR 0.42(95%CI 0.27-0.67,p<0.001);后期神经科随访 aOR 0.16(95%CI 0.13-0.21,p<0.001);后期初级保健随访 aOR 0.16(95%CI 0.14-0.17,p<0.001),均与再入院 odds 降低相关。

临床怎么用

  • 出院规划应重视确保患者获得初级保健或神经科门诊随访。
  • 门诊随访可能作为减少老年癫痫/惊厥患者再入院的简易干预措施。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Older adults are expected to have higher readmission rates after seizure-related hospitalization. We sought to define the 30-day readmission rate for older adults after seizure hospitalization and to examine whether occurrence, timing, or specialization of follow-up with primary or neuro-related care is associated with lower readmission risk. METHODS: This is a retrospective cohort study using 2016-2019 Medicare claims data, including adults aged older than 65 years hospitalized with a primary diagnosis of seizure/epilepsy. The primary outcome was readmission within 30 days. Exposure of interest was presence or absence of follow-up and specialty of the follow-up provider. Beneficiaries were followed from 90 days before admission to 30 days after discharge. We defined variables a priori based on literature/clinical judgment and used a least absolute shrinkage and selection operator (LASSO) method to determine factors that were contributing to the data's variance for inclusion in the final model. RESULTS: Of 80,620 beneficiaries with admissions for seizure/epilepsy, 17.72% were readmitted within 30 days. Overall, 20.6% saw only primary care, 2.5% neurology only, 0.3% neurosurgery only, and 0.1% epilepsy only, and 5.4% had a combination of visits. Readmission rates differed by follow-up visit status: 22% readmission rate for those with no follow-up and only 6% with any health care visit. Among those with a visit, the readmission rates by specialty were as follows: 8% for primary care alone, 5% for neurology alone, 16% for neurosurgery alone, 1% for epileptology alone, and 2% for those who had seen a combination of these specialties. In our LASSO-selected multivariable model, outpatient follow-up was associated with lower odds of readmission: early (days 1-15) primary care visit (adjusted odds ratio [aOR] 0.49; 95% CI 0.45-0.52, p < 0.001); early neurology visit (aOR 0.39; 95% CI 0.33-0.46, p < 0.001); and later (days 16-30) neurosurgery visit (aOR 0.42; 95% CI 0.27-0.67, p < 0.001), later neurology visit (aOR 0.16; 95% CI 0.13-0.21, p < 0.001), or later primary care visit (aOR 0.16; 95% CI 0.14-0.17, <0.001), all associated with reduced odds of readmission. DISCUSSION: We found high rates of readmission in older adults. Outpatient follow-up was associated with reduced odds of readmission. These findings reinforce the importance of discharge planning and suggest that ensuring outpatient follow-up with either primary care or neurology may be an easy intervention to reduce readmissions.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Blank LJ, Van Hyfte G, Agarwal P, et al. Association of Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge in Medicare Beneficiaries Aged 65 and Older. Neurology. 2025. PMID: 40340379. doi:10.1212/WNL.0000000000213638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。